Roger L. Milne

56.8k total citations
246 papers, 5.9k citations indexed

About

Roger L. Milne is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Roger L. Milne has authored 246 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Oncology, 82 papers in Genetics and 64 papers in Molecular Biology. Recurrent topics in Roger L. Milne's work include BRCA gene mutations in cancer (60 papers), Cancer Risks and Factors (38 papers) and Epigenetics and DNA Methylation (38 papers). Roger L. Milne is often cited by papers focused on BRCA gene mutations in cancer (60 papers), Cancer Risks and Factors (38 papers) and Epigenetics and DNA Methylation (38 papers). Roger L. Milne collaborates with scholars based in Australia, United States and United Kingdom. Roger L. Milne's co-authors include Graham G. Giles, John L. Hopper, Dallas R. English, Melissa C. Southey, Kelly‐Anne Phillips, Michael Friedländer, Allison Hodge, Pierre‐Antoine Dugué, Julie K. Bassett and Nina Afshar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Roger L. Milne

241 papers receiving 5.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger L. Milne Australia 44 2.0k 1.8k 1.6k 943 839 246 5.9k
Joellen M. Schildkraut United States 51 1.7k 0.9× 2.3k 1.3× 2.2k 1.4× 1.2k 1.3× 946 1.1× 219 8.7k
Gianluca Severi France 45 1.6k 0.8× 1.8k 1.0× 817 0.5× 824 0.9× 735 0.9× 226 6.5k
Anne Zeleniuch‐Jacquotte United States 52 3.3k 1.6× 2.1k 1.2× 1.9k 1.2× 1.3k 1.3× 1.4k 1.6× 168 8.9k
Sue A. Ingles United States 45 1.4k 0.7× 2.0k 1.1× 1.6k 1.0× 809 0.9× 882 1.1× 126 6.6k
Alan A. Arslan United States 44 1.9k 0.9× 1.4k 0.8× 1.2k 0.8× 819 0.9× 1.4k 1.6× 130 6.2k
Sabina Rinaldi France 40 1.7k 0.8× 1.6k 0.9× 842 0.5× 821 0.9× 719 0.9× 116 4.7k
Konstantinos K. Tsilidis Greece 41 1.7k 0.8× 1.5k 0.8× 661 0.4× 955 1.0× 940 1.1× 162 7.0k
Britton Trabert United States 41 1.8k 0.9× 2.0k 1.1× 823 0.5× 1.5k 1.6× 765 0.9× 173 7.7k
Janet E. Olson United States 38 1.2k 0.6× 1.0k 0.6× 807 0.5× 798 0.8× 917 1.1× 155 5.1k
Carol Sweeney United States 45 3.3k 1.6× 2.0k 1.1× 1.1k 0.7× 1.3k 1.4× 1.1k 1.3× 138 6.9k

Countries citing papers authored by Roger L. Milne

Since Specialization
Citations

This map shows the geographic impact of Roger L. Milne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger L. Milne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger L. Milne more than expected).

Fields of papers citing papers by Roger L. Milne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger L. Milne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger L. Milne. The network helps show where Roger L. Milne may publish in the future.

Co-authorship network of co-authors of Roger L. Milne

This figure shows the co-authorship network connecting the top 25 collaborators of Roger L. Milne. A scholar is included among the top collaborators of Roger L. Milne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger L. Milne. Roger L. Milne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergin, Rebecca J., Deirdre O’Sullivan, Suzanne C. Dixon‐Suen, et al.. (2024). Time to Diagnosis and Treatment for Ovarian Cancer and Associations with Outcomes: A Systematic Review. Journal of Women s Health. 33(9). 1185–1197. 3 indexed citations
2.
Hodge, Allison, Melissa C. Southey, Graham G. Giles, et al.. (2024). Physical activity and DNA methylation–based markers of ageing in 6208 middle-aged and older Australians: cross-sectional and longitudinal analyses. GeroScience. 47(2). 2263–2274. 3 indexed citations
3.
Peng, Yang, Julie K. Bassett, Allison Hodge, et al.. (2023). Adherence to 2018 WCRF/AICR Cancer Prevention Recommendations and Risk of Cancer: The Melbourne Collaborative Cohort Study. Cancer Epidemiology Biomarkers & Prevention. 33(1). 43–54. 2 indexed citations
4.
Yang, Yi, Fiona Bruinsma, Anna K. Nowak, et al.. (2022). Physical activity and glioma: a case–control study with follow-up for survival. Cancer Causes & Control. 33(5). 749–757. 1 indexed citations
5.
Dashti, S. Ghazaleh, Allison Hodge, Suzanne C. Dixon‐Suen, et al.. (2022). Mechanisms for the Sex-Specific Effect of H. Pylori on Risk of Gastroesophageal Reflux Disease and Barrett's Esophagus. Cancer Epidemiology Biomarkers & Prevention. 31(8). 1630–1637. 5 indexed citations
6.
Bassett, Julie K., Robert J. MacInnis, Yi Yang, et al.. (2022). Alcohol intake trajectories during the life course and risk of alcohol‐related cancer: A prospective cohort study. International Journal of Cancer. 151(1). 56–66. 7 indexed citations
7.
Hurson, Amber N., Parichoy Pal Choudhury, Chi Gao, et al.. (2021). Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countries. International Journal of Epidemiology. 50(6). 1897–1911. 43 indexed citations
8.
Steinberg, Julia, Mark M. Iles, Xiaochuan Wang, et al.. (2021). Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts*. British Journal of Dermatology. 186(5). 823–834. 12 indexed citations
9.
Milne, Roger L., et al.. (2021). Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence. Cancer Prevention Research. 14(11). 983–994. 10 indexed citations
10.
Dugué, Pierre‐Antoine, Julie K. Bassett, Ee Ming Wong, et al.. (2020). Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study. JNCI Cancer Spectrum. 5(1). 47 indexed citations
11.
Li, Shuai, Tuong L. Nguyen, Ee Ming Wong, et al.. (2020). Genetic and environmental causes of variation in epigenetic aging across the lifespan. Clinical Epigenetics. 12(1). 158–158. 34 indexed citations
12.
Dugué, Pierre‐Antoine, Julie K. Bassett, Roger L. Milne, et al.. (2020). DNA Methylation in Peripheral Blood and Risk of Gastric Cancer: A Prospective Nested Case–control Study. Cancer Prevention Research. 14(2). 233–240. 2 indexed citations
13.
Saunders, Christobel, Louise Keogh, Danielle Mazza, et al.. (2020). Breast Cancer Chemoprevention: Use and Views of Australian Women and Their Clinicians. Cancer Prevention Research. 14(1). 131–144. 7 indexed citations
14.
Doo, Nicole Wong, Victoria White, Kara Martin, et al.. (2019). The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment. Cancers. 11(7). 928–928. 4 indexed citations
15.
Gaudet, Mia M., Gretchen L. Gierach, Brian D. Carter, et al.. (2018). Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype. Cancer Research. 78(20). 6011–6021. 61 indexed citations
16.
Lee, Yeh Chen, Roger L. Milne, Charmaine Smith, et al.. (2016). Risk of uterine cancer in BRCA1 and BRCA2 mutation carriers.. Journal of Clinical Oncology. 34(15_suppl). 1529–1529. 1 indexed citations
17.
Phillips, Kelly‐Anne, Ian Collins, Roger L. Milne, et al.. (2016). Anti-Müllerian Hormone Serum Concentrations of Women With Germline BRCA1 or BRCA2 Mutations. Obstetrical & Gynecological Survey. 71(8). 474–475. 8 indexed citations
18.
Mocci, Evelina, Roger L. Milne, John L. Hopper, et al.. (2013). Risk of Pancreatic Cancer in Breast Cancer Families from the Breast Cancer Family Registry. Cancer Epidemiology Biomarkers & Prevention. 22(5). 803–811. 61 indexed citations
19.
Heikkinen, Tuomas, Kirsimari Aaltonen, Roger L. Milne, et al.. (2009). The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype. Clinical Cancer Research. 15(9). 3214–3222. 94 indexed citations
20.
Vadlamudi, Lata, Marianne Juel Kjeldsen, Linda A. Corey, et al.. (2006). Analyzing the Etiology of Benign Rolandic Epilepsy: A Multicenter Twin Collaboration. Epilepsia. 47(3). 550–555. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joellen M. Schildkraut Breakdown of academic impact, for papers by Gianluca Severi Breakdown of academic impact, for papers by Anne Zeleniuch‐Jacquotte Breakdown of academic impact, for papers by Sue A. Ingles Breakdown of academic impact, for papers by Alan A. Arslan Breakdown of academic impact, for papers by Sabina Rinaldi Breakdown of academic impact, for papers by Konstantinos K. Tsilidis Breakdown of academic impact, for papers by Britton Trabert Breakdown of academic impact, for papers by Janet E. Olson Breakdown of academic impact, for papers by Carol Sweeney
Rankless by CCL
2026